Rosa G. Macancela
Nurse Practitioners (Nurse Practitioner)
At a glance
- Years since graduation
- 5
- In the NPI registry since
- 2015
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2015Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nurse Practitioner primary
NY license F310560-01 -
Adult Health Nurse Practitioner
NY license 310560 -
Registered Nurse
NY license 708130-1
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mount Sinai Hospital New York, NY
Medical groups
- Icahn School of Medicine at Mount Sinai (2,843 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Metoprolol Succinate Other prescribers in New York, NY | 28 |
| Ezetimibe Other prescribers in New York, NY | 20 |
| Repatha Sureclick (evolocumab) Other prescribers in New York, NY | 18 |
| Spironolactone Other prescribers in New York, NY | 12 |
| Atorvastatin Calcium Other prescribers in New York, NY | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 15 companies reported 100 payments worth $3,730 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $1,048 |
|---|---|
| Cvrx, Inc. | $507 |
| Bridgebio Pharma, Inc. | $462 |
| E.r. Squibb & Sons, L.l.c. | $365 |
| Alnylam Pharmaceuticals Inc. | $242 |
| Novartis Pharmaceuticals Corporation | $234 |
| Novo Nordisk Inc | $192 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $139 |
| Food and Beverage | $3,224 |
|---|---|
| Travel and Lodging | $507 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Cvrx, Inc. Dec 30, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Atlanta, GA | $473 |
| Cvrx, Inc. Dec 30, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Nashville, TN | $34.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.